Age-related macular degeneration is the principal cause of registered legal blindness
among those aged over 65 in the United States, western Europe, Australia, and Japan …

Purpose To review current knowledge of key pathogenetic pathways in age-related macular
disease (AMD). Methods Experimental evidence and clinical observations are reviewed …

Age-related macular degeneration (AMD) is a disease of the outer retina, characterized most
significantly by atrophy of photoreceptors and retinal pigment epithelium accompanied with …

PURPOSE: To review the evidence that exists concerning the pathogenesis of lesions in late
age-related macular disease (AMD). DESIGN: Review of the literature. METHODS: A review …

PURPOSE: To present the current understanding of age-related macular degeneration
(AMD) pathogenesis, based on clinical evidence, epidemiologic data, histopathologic …

Neovascular age-related macular degeneration (AMD) is a complex disease in which an
individual's genetic predisposition is affected by aging and environmental stresses, which …

Purpose: To address the most dynamic and current issues concerning human genetics, risk
factors, pharmacoeconomics, and prevention regarding age-related macular degeneration …

As the age of the population increases in many nations, age‐related degenerative diseases
pose significant socioeconomic challenges. One of the key degenerative diseases that …

Age-related macular degeneration is the leading cause of irreversible blindness in people
50 years of age or older in the developed world. This article reviews the clinical and …

Age-related macular degeneration (AMD) is the leading cause of vision loss and blindness
among older adults in the USA and throughout the developed world. Etiological research …